NCT05970211

Brief Summary

The purpose of this clinical trial pilot is to obtain feasibility and pilot data necessary to inform the hearing intervention being designed for a larger R01 clinical trial that seeks to determine whether best practice hearing aid intervention impacts hearing-related outcomes in adults with hearing loss aged 55 to 75 years. Secondary purposes include: To determine what effects best practice hearing aid intervention has on physical, social, and quality of life outcomes in adults with hearing loss aged 55 to 75 years.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2023

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2024

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

10 months

First QC Date

July 6, 2023

Last Update Submit

July 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Objective Physical Activity

    Activity level as measured by research-grade accelerometer

    2-week measurement taken between 4- and 6- months post study enrollment

Secondary Outcomes (18)

  • Words in Noise Test

    Measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment

  • International Outcome Inventory for Comprehensive Hearing Intervention

    Measured at 6-months post study enrollment

  • Client Oriented Scale of Improvement

    Measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment

  • Hearing Handicap Inventory for Adults

    Measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment

  • Center for Epidemiological Studies Depression and Hopelessness Scale

    Measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment

  • +13 more secondary outcomes

Study Arms (1)

Hearing Intervention Group

EXPERIMENTAL

Adults aged 55-75 with hearing loss who have little/no prior experience with hearing aids will be enrolled in the hearing intervention group.

Device: Phonak Audeo Lumity Receiver in Canal Hearing Aid

Interventions

bilateral receiver in canal hearing aids provided as part of a best practices hearing loss intervention including devices, hearing centered counseling, and self management skills training for hearing loss

Hearing Intervention Group

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 55 to 75 years old with little or no experience with hearing aids
  • English or Spanish speakers

You may not qualify if:

  • Unable to complete written questionnaires on a tablet without assistance
  • Refer for cognitive screening score based on criteria using the Mini Mental State Examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Florida

Tampa, Florida, 33620, United States

RECRUITING

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Michelle Arnold, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 6, 2023

First Posted

August 1, 2023

Study Start

June 19, 2023

Primary Completion

April 15, 2024

Study Completion

August 15, 2024

Last Updated

August 1, 2023

Record last verified: 2023-07

Locations